» Articles » PMID: 30232280

Imbalance of Immunological Synapse-kinapse States Reflects Tumor Escape to Immunity in Glioblastoma

Abstract

Since the proper activation of T cells requires the physical interaction with target cells through the formation of immunological synapses (IS), an alteration at this level could be a reason why tumors escape the immune response. As part of their life cycle, it is thought that T cells alternate between a static phase, the IS, and a dynamic phase, the immunological kinapse (IK), depending on high or low antigen sensing. Our investigation performed in tissue samples of human glioma shows that T cells are able to establish synapsing interactions not only with glioma tumorigenic cells, but also with stromal myeloid cells. Particularly, the IS displaying a T cell receptor-rich (TCR-rich) central supramolecular activation cluster (cSMAC) is preferentially established with stromal cells, as opposed to malignant cells. Conversely, T cells in the malignant areas showed distinct morphometric parameters compared with nonneoplastic tissue - the former characterized by an elongated shape, well-suited to kinaptic dynamics. Importantly, high-resolution 3-dimensional analyses demonstrated the existence of bona-fide IK preferentially arranged in malignant areas of the tumor. This imbalance of IS/IK states between these 2 microenvironments reveals the low antigenic sensing of T cells when patrolling tumorigenic cells and reflects the immunoevasive environment of the tumor.

Citing Articles

Subverting to Prevent : Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion.

Mastrogiovanni M, Donnadieu E, Pathak R, Di Bartolo V Biology (Basel). 2024; 13(11).

PMID: 39596815 PMC: 11591779. DOI: 10.3390/biology13110860.


The Three Pillars of Glioblastoma: A Systematic Review and Novel Analysis of Multi-Omics and Clinical Data.

De Luca C, Virtuoso A, Papa M, Cirillo G, La Rocca G, Corvino S Cells. 2024; 13(21.

PMID: 39513861 PMC: 11544881. DOI: 10.3390/cells13211754.


Explainable machine learning for profiling the immunological synapse and functional characterization of therapeutic antibodies.

Boushehri S, Essig K, Chlis N, Herter S, Bacac M, Theis F Nat Commun. 2023; 14(1):7888.

PMID: 38036503 PMC: 10689847. DOI: 10.1038/s41467-023-43429-2.


Development of bispecific T cell engagers: harnessing quantitative systems pharmacology.

Qi T, Liao X, Cao Y Trends Pharmacol Sci. 2023; 44(12):880-890.

PMID: 37852906 PMC: 10843027. DOI: 10.1016/j.tips.2023.09.009.


Innate immune response restarts adaptive immune response in tumors.

Li W, Zhang Q, Li Q, Liu S, Yuan G, Pan Y Front Immunol. 2023; 14:1260705.

PMID: 37781382 PMC: 10538570. DOI: 10.3389/fimmu.2023.1260705.


References
1.
Dustin M . The cellular context of T cell signaling. Immunity. 2009; 30(4):482-92. PMC: 2905632. DOI: 10.1016/j.immuni.2009.03.010. View

2.
Berghoff A, Kiesel B, Widhalm G, Rajky O, Ricken G, Wohrer A . Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma. Neuro Oncol. 2014; 17(8):1064-75. PMC: 4490866. DOI: 10.1093/neuonc/nou307. View

3.
Yang J, Sanderson N, Wawrowsky K, Puntel M, Castro M, Lowenstein P . Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo. Proc Natl Acad Sci U S A. 2010; 107(10):4716-21. PMC: 2842057. DOI: 10.1073/pnas.0911587107. View

4.
Moreau H, Lemaitre F, Terriac E, Azar G, Piel M, Lennon-Dumenil A . Dynamic in situ cytometry uncovers T cell receptor signaling during immunological synapses and kinapses in vivo. Immunity. 2012; 37(2):351-63. DOI: 10.1016/j.immuni.2012.05.014. View

5.
Fife B, Pauken K, Eagar T, Obu T, Wu J, Tang Q . Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat Immunol. 2009; 10(11):1185-92. PMC: 2778301. DOI: 10.1038/ni.1790. View